Certification in Psychedelic Assisted Therapy (PAT)
In-depth training for the emerging field of psychedelic therapy — built for practitioners who value skill, ethics, and responsibility. Backed by research. Informed by real-world experience.
Welcome to Australian Practitioners
Regulation of Psychedelic Prescribing in Australia
Welcome!
Mark Haden
Dr. Devon Christie
Bruce Sanguin
Saundra Jain
Dr. Rakesh Jain
Dr. Anthony Bossis
Kim Haxton
Dr. Ben Malcolm
Alex Belser
Dr. Pam Kryskow
Zach Walsh
Dr. Ravinder Bains
Dr. Monika Hooper
M1 Overview: Psychedelics are Medicine - Mark Haden
M1 Overview: The Categories of Psychedelics - Mark Haden
M1 Overview: Psychedelics - Nature vs Lab - Dr. Rakesh Jain
M1 Overview: Are manmade compounds missing out on the full spectrum of what nature can provide? - Dr. Rakesh Jain
M1 Overview: The Benefits of the Psychedelic Experience - Alex Belser
M1 Overview: Psychedelics and the Prescriber - Monika Hooper
M1 Overview: Psychedelics in the Context of Holistic Psychiatric Care - Monika Hooper
M1 History: History Of Psychedelics - Mark Haden
M1: History: Untold History Of Psychedelics - Mark Haden
M1 Current Study and Research of Psychedelics: Section 56 Exemptions, SAP and Trials-Accessing Psychedelics - Mark Haden
M1 Current Study and Research of Psychedelics: Microdosing Psychedelics - Zach Walsh
M1 BONUS MATERIAL: Current Study and Research of Psychedelics: Microdosing Survey Outcomes - Zach Walsh
M1 Current Study and Research of Psychedelics: Psychedelics and Wellness Study 2019 - Saundra Jain
M2 The Psychedelic Medicines-Types and Descriptions: Psilocybin - Mark Haden
M2 The Psychedelic Medicines-Types and Descriptions: MDMA - Mark Haden
M2 The Psychedelic Medicines-Types and Descriptions: MDMA and Psilocybin-Clinical Indications - Alex Belser
M2 The Psychedelic Medicines-Types and Descriptions: DMT and 5-MeO-DMT - Mark Haden
M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions: 2C-B - Mark Haden
M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions: 3-MMC - Mark Haden
M2 The Psychedelic Medicines-Types and Descriptions: LSD - Mark Haden
M2 BONUS MATERIAL: The Psychedelic Medicines-Types and Descriptions : MEAI - Mark Haden
M2 The Psychedelic Medicines-Types and Descriptions: Ketamine - Uses and Benefits - Rakesh Jain
M2 The Psychedelic Medicines-Types and Descriptions: Maximizing The Benefits in Ketamine Application - Dr. Rakesh Jain
M2 The Psychedelic Medicines-Types and Descriptions: Psychedelics And The Four Neurotransmitters - Dr Rakesh Jain
M2 The Psychedelic Medicines-Types and Descriptions: Comparing Effects and Outcomes of Psilocybin, MDMA and Ketamine Therapy - Zach Walsh
M2 The Psychedelic Medicines-Neurobiology: Pharmacology in Relation to Psychedelics - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Neurobiology and Effects of Psychedelics - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Leading Theories in Neurobiology for Psychedelics - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Overview of MDMA - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: MDMA Side Effects - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: MDMA Pharmacodynamics - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: MDMA Pharmacokinetics - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology : MDMA Drug Interactions - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Seratonin Syndrome/Toxicity - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Overview of Psilocybin - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Psilocybin Pharmacodynamics and Pharmacokinetics - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Psilocybin Drug Interactions - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Ketamine Overview - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Ketamine Pharmacodynamics - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Ketamine Pharmacokinetics - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology : Ketamine Drug Interactions - Ben Malcolm
M2 The Psychedelic Medicines-Neurobiology: Final Thoughts-The Data Will Set Us Free - Ben Malcolm
M3 Access and Inclusivity: Indigenous Perspectives - Benefits of Medicine Circles and Individual Ceremonies - Kim Haxton
M3 Access and Inclusivity: Indigenous Perspectives - Bridging The Gap With Psychedelics - Kim Haxton
M3 Access and Inclusivity: Indigenous Perspectives - Indigenous-Informed Ways to Offer Psychedelics to Diverse Populations - Kim Haxton
M3 Access and Inclusivity: Indigenous Perspectives - Settler Reflexivity - Kim Haxton
M3 Access for Diverse and Under-privileged Populations: Making a difference in First Nations Communities - Kim Haxton
M3 Access for Diverse and Under-privileged Populations: Challenges of Access for Diverse Populations - Kim Haxton
M3 Access for Diverse and Under-privileged Populations: Reciprocity - Kim Haxton
M3 Access for Diverse and Under-privileged Populations: The Future of Accessibility - Alex Belser
M3 Access for Diverse and Under-privileged Populations: The Challenge of Accessibility to Psychedelic Treatments - Monika Hooper
M3 Access for Diverse and Under-privileged Populations: The Special Access Program (SAP) Process for Psilicybin and MDMA - Monika Hooper
M3 Cultural Considerations: Cross Cultural Considerations - Kim Haxton
M3 Cultural Considerations: What We Need To Know About Psychedelics, LGBTQIA+ and BIPOC - Alex Belser
M4 The Therapeutic Facilitator: The Role of a Prescriber in Referring to a PaT Facilitator - Rakesh Jain
M4 Basic Principles of Guiding/Sitting: - The Value Of Working Within A Team Of Psychedelic Therapists - Pam Kryskow
M4 Basic Principles of Guiding/Sitting: A Pragmatic Approach to Trauma-Informed Psychedelic Work - Rakesh Jain
M4 Self-Care for the Facilitator: Therapist Support Networks for Self-Care - Saundra Jain
Depending on your location, options to spread your payments will be available on the checkout page.